LEADER 05622nam 2201525z- 450 001 9910566469103321 005 20220506 035 $a(CKB)5680000000037689 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81066 035 $a(oapen)doab81066 035 $a(EXLCZ)995680000000037689 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCOVID-19: Current Challenges and Future Perspectives 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (264 p.) 311 08$a3-0365-3118-1 311 08$a3-0365-3119-X 330 $aOn March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both hemispheres as well as to the economies of each country. The morbidity and mortality due to infections caused by SARS-CoV-2 have been significant despite the short duration since its discovery and initially overwhelmed many hospitals and clinics. It influences everyone, and countermeasures have been dramatic in their impact on employment, social systems, and mental health. This Special Issue provides an avenue for authors from various disciplines to provide feedback on our responses and preparedness to COVID-19 globally as well as to disseminate critical information about the SARS-CoV-2 virus and the associated COVID-19 pandemic. It consists of 22 peer-reviewed papers that cover worldwide perspectives encompasses the following: Original articles about COVID-19 (including epidemiology, modelling, clinical data, treatment, prevention, countermeasures, impacts on tropical regions, response, and preparedness);Original articles about SARS-CoV-2 (microbiology, virology, transmission, pathology, and vaccinology);Perspectives about COVID-19 and SARS-CoV-2 (comparisons with past coronavirus outbreaks, impactful local initiatives, novel responses, and commentaries);Reviews on COVID-19 (based on systematic and narrative reviews);and Innovations (vaccine development, drug trials, and original countermeasures). 517 $aCOVID-19 606 $aEnvironmental medicine$2bicssc 606 $aMedicine and Nursing$2bicssc 610 $aAfrica 610 $aalcohol-related liver disease 610 $aantiretroviral therapy 610 $aattitudes 610 $aBangladesh 610 $abowel perforation 610 $aChagas disease 610 $achronic kidney disease 610 $acirrhosis 610 $aclinical trials 610 $aCMV 610 $acognitive bias 610 $acoinfections 610 $acontrol 610 $acoronavirus 610 $aCOVID-19 610 $aCOVID-19 vaccines 610 $acytokine release syndrome 610 $acytokine storm 610 $aD-Dimer 610 $adiagnostic reasoning 610 $adifferential diagnosis 610 $aefficacy 610 $aemergency 610 $aendemic 610 $aEpiCollect5 610 $aepidemiology 610 $aethics 610 $afecal calprotectin 610 $ageneral practitioners 610 $aHarare 610 $ahealth care workers 610 $ahealth systems 610 $ahealthcare personnel 610 $ahealthcare worker 610 $ahealthcare workers 610 $aheart transplant 610 $ahepatitis B and C 610 $aHIV 610 $aIL-6 inhibitors 610 $aimpact 610 $aIndia 610 $ainfection 610 $ainfluenza 610 $aischemia 610 $akaletra 610 $aKenya 610 $aknowledge 610 $aLilongwe 610 $alopinavir/ritonavir 610 $amalaria 610 $aMalawi 610 $aMDR-TB 610 $amedical doctor 610 $aMERS 610 $ameta-analysis 610 $amortality 610 $an/a 610 $aNairobi 610 $anecrosis 610 $aNepal 610 $anonalcoholic steatohepatitis 610 $aoperational research 610 $aoverview 610 $apandemic 610 $apandemics 610 $aperceptions 610 $aPhilippines 610 $aplasmodium falciparum 610 $apost-acute COVID-19 syndrome 610 $apreparedness 610 $apresumptive tuberculosis 610 $apublic health 610 $areal-time operational research 610 $arecurrence 610 $areinfection 610 $aresearch capacity building 610 $arespiratory viruses 610 $arhinovirus 610 $asafety 610 $aSARS 610 $aSARS-CoV-1 610 $aSARS-CoV-2 610 $asevere acute respiratory syndrome coronavirus 2 610 $aseverity 610 $aSORT IT 610 $aTB treatment outcomes 610 $athrombosis 610 $atocilizumab 610 $atraining 610 $atuberculosis 610 $aZimbabwe 615 7$aEnvironmental medicine 615 7$aMedicine and Nursing 700 $aLeggat$b Peter$4edt$01309623 702 $aFrean$b John$4edt 702 $aBlumberg$b Lucille$4edt 702 $aLeggat$b Peter$4oth 702 $aFrean$b John$4oth 702 $aBlumberg$b Lucille$4oth 906 $aBOOK 912 $a9910566469103321 996 $aCOVID-19: Current Challenges and Future Perspectives$93029465 997 $aUNINA